|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3866850 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19798464.4 |
| Date of filing the European patent application | 2019-10-18 | |
| (97) | Date of publication of the European application | 2021-08-25 |
| (45) | Date of publication and mention of the grant of the patent | 2024-07-24 |
| (46) | Date of publication of the claims translation | 2024-09-10 |
| (86) | Number | PCT/US2019/056923 |
| Date | 2019-10-18 |
| (87) | Number | WO 2020/081928 |
| Date | 2020-04-23 |
| (30) | Number | Date | Country code |
| 201862748089 P | 2018-10-19 | US |
| (72) |
MAURER, Matthew , US
SIMONSEN, Katy L. , US
|
| (73) |
Bristol-Myers Squibb Company ,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kompleksinė melanomos terapija |
| COMBINATION THERAPY FOR MELANOMA |
| Payment date | Validity (years) | Amount | |
| 2025-09-19 | 7 | 162.00 EUR |
| 2026-10-18 |